Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2300877	重组抗CD20人源化单克隆抗体皮下注射液	Recombinant anti-CD20 humanized monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2023-12-22		Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd			view
CXSL2000334	重组抗CD20人源化单克隆抗体皮下注射液	Recombinant anti-CD20 humanized monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2020-11-28	上海交联药物研发有限公司	Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd	In Review	2020-11-27	view
CXSL2300798	重组抗CD20人源化单克隆抗体皮下注射液	Recombinant anti-CD20 humanized monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2023-11-22		Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd			view
CXSL2300427	重组抗CD20人源化单克隆抗体皮下注射液	Recombinant anti-CD20 humanized monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2023-06-22		Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd			view
CXSL2200277	重组抗CD20人源化单克隆抗体皮下注射液	Recombinant anti-CD20 humanized monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2022-06-16		Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd			view